Jonathan Peri
CIK: 0002149660
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CTOR
CITIUS ONCOLOGY, INC.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Peri Jonathan
Peri Jonathan (SEC CIK 0002149660) files insider reports with the SEC as Director of CITIUS ONCOLOGY, INC. (CTOR).
Signal8 holds 1 ownership filing by Peri Jonathan, a Form 3, filed on Aug 14, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Peri Jonathan's filings is in CRANFORD, NJ.
Other insiders filing for CITIUS ONCOLOGY, INC. (CTOR)
- Webb Carol, Director
- HOLUBIAK MYRON Z, Secretary
- Czuczman Myron, Chief Medical Officer
- Bartushak Jaime, Chief Financial Officer
- Mazur Leonard L, Chief Executive Officer
- Smith Robert Joseph, Director